Gastroenterology is the branch of medicine that deals with the digestive system. The focus of this speciality is diseases of the gastrointestinal tract, which includes the organs from the mouth to the anus, including the oesophagus, stomach, small intestine, large intestine, rectum, pancreas, gallbladder, bile ducts and liver.
Janssen’s worldwide leadership in gastroenterology has been established from a 30-year heritage of innovation and scientific breakthroughs. For over two decades, we have been a world leader in the development of treatments for patients with Inflammatory Bowel Disease (IBD) and have transformed their lives.
We foster active collaborations with academia, emerging companies, patients, and patient groups to accelerate innovation and achieve our shared goals in tackling gastroenterology-related disease.
Inflammatory Bowel Disease (IBD) is a group of conditions that cause chronic (long-term or life-long) inflammation of the gastrointestinal (GI) tract, the two most common of which are Crohn’s disease (CD) and ulcerative colitis (UC).